Automated Laboratory Market is Poised to Witness Significant Growth due to Rising Need for Standardized Results


 Laboratory automation refers to adopting automation technologies and processes in laboratories to perform laboratory tests and experiments with minimal human assistance. It helps in standardizing test results, reducing manual errors, increasing productivity and throughput, and optimizing resource utilization. Rapid increase in test volumes due to rising disease prevalence, growing demand for error-free high-throughput screening, and the need to improve operational efficiency have boosted adoption of lab automation systems globally.

The global lab automation market is estimated to be valued at US$ 4,903.9 Mn in 2024 and is expected to exhibit a CAGR of 4.9% over the forecast period 2023 to 2030.

Key Takeaways
Key players operating in the lab automation market are Tecan Trading AG, PerkinElmer Inc., Danaher, Thermo Fisher Scientific, QIAGEN, Agilent Technologies, Inc., Hamilton Company, COPAN Diagnostics Inc., Abbott, Merck KGaA, F. Hoffmann-La Roche Ltd, Siemens Healthcare Private Limited, UiPath, and Porvair Sciences, SPT Labtech Ltd, Endress+Hauser Group Services AG, Automata, accroma, Molecular Devices, LLC, Beckman Coulter, Inc., BD, Reshape Biotech, Peak Analysis & Automation.

Major market players are focusing on new product launches, mergers & acquisitions, geographical expansion and increased R&D investments to gain a competitive edge in the market. For instance, Thermo Fisher acquired clinical diagnostics company Henrik Biotech recently to expand in Asia Pacific region. In addition, growing demand for personalized medicine, point-of-care testing, and biobanking applications provides major opportunities for players in this market. Geographically as well, North America is expected to dominate the lab automation market owing to high healthcare spending, while Asia Pacific is anticipated to grow at the fastest pace during the forecast period.

Market Drivers:
1. Growing pressure to reduce healthcare costs is a major growth driver for the lab automation market. Adopting automated systems helps labs improve productivity and throughput, while reducing manual errors and wastage of consumables. This positively impacts the overall cost of testing.
2. Rapid increase in test volumes across various industries including biomedical, pharmaceutical, food & beverage and clinical diagnostics is propelling demand for automated systems. It helps optimize resource utilization and scale up operations to handle high volume without compromising on quality and turnaround time.

Market Restrains:
1. High initial costs associated with procuring and installing automated systems is a key challenge, especially for small and medium labs. This restrains widespread adoption of automation technologies.
2. Lack of skilled technicians who can seamlessly integrate and operate complex automated systems also limits market growth to some extent. Extensive training is required to operate different modules of automated workflow.


Segment Analysis

The global lab automation market is dominated by the equipment segment. Automated equipment such as automated clinical instruments, robotic systems, motion control systems, automated storage and retrieval systems are extensively used in various research and clinical laboratories to streamline workflows and increase efficiency. The widespread adoption of automated equipment is due to the high throughput capacity and enhanced performance they deliver compared to manual operations. This high productivity helps laboratories to process more tests and samples without compromising quality, thereby saving significant time and costs.

Global Analysis

Regionally, North America holds the major share in the global lab automation market and is expected to continue its dominance during the forecast period. Extensive R&D activities in pharmaceutical and biotechnology industries, rising government funding for life science research, presence of leading automation equipment manufacturers, and growing adoption of personalized medicine are some key factors driving the North American market. Asia Pacific is projected to be the fastest growing region owing to rising healthcare spending, increasing number of CROs and biopharma companies establishing operations in China, India and South Korea, and growing public and private initiatives to enhance lab infrastructure and capabilities in the region. Robotic systems are gaining widespread adoption in key Asia Pacific countries like China and India as they help address the shortage of skilled labor in laboratories. Regionally advanced countries like Japan are also increasingly automating laboratory processes.

Comments

Post a Comment

Popular posts from this blog

Unveiling Health Secrets: Exploring the Potential of Blood-Based Biomarkers

Image
  The human body is a complex and intricate system, often harboring subtle signs of its inner workings. One of the most promising avenues for unlocking these secrets lies within our bloodstream – a treasure trove of information encoded in the form of blood-based biomarkers. These biomarkers, measurable indicators present in the blood, hold the potential to revolutionize healthcare by providing early detection, accurate diagnosis, and personalized treatment approaches. Blood-based biomarkers encompass a wide range of molecules – from proteins and nucleic acids to metabolites and even circulating cells. Researchers have been diligently working to identify specific biomarkers associated with various diseases and conditions. For instance, elevated levels of certain proteins might point to cardiovascular diseases, while specific genetic material could indicate the presence of cancer. By analyzing these biomarkers, clinicians gain valuable insights into an individual's health status, en...
Read more

Revolutionizing Biology: Advancements in Single Cell Analysis Techniques

Image
  Single cell analysis has emerged as a groundbreaking technology that is revolutionizing the field of biology. Traditionally, biological studies were conducted on populations of cells, averaging out the heterogeneity present within them. However, the advent of single cell analysis has enabled scientists to delve into the complexity of individual cells, uncovering a wealth of previously inaccessible information. Advancements in single cell analysis techniques have paved the way for a deeper understanding of cellular heterogeneity, gene expression, and cellular behavior. One of the most remarkable techniques is single-cell RNA sequencing (scRNA-seq), which allows scientists to measure gene expression in individual cells. This breakthrough has led to the identification of rare cell types, understanding of cellular communication networks, and the discovery of novel biomarkers. Moreover, single cell imaging techniques, such as single cell fluorescence microscopy, have enabled research...
Read more

Medical Robots Market Poised to Grow Owing to Improving Healthcare Infrastructure

Image
 The Medical Robots Market is anticipated to witness robust growth due to rising healthcare spending across the globe. Medical robots are used to perform minimal invasive surgeries with greater accuracy and flexibility. Growing preference for Robot-Assisted Surgery (RAS) over conventional open surgeries due to benefits such as shorter recovery time and minimum operative scars has been augmenting demand for medical robots. Key functions include guiding and positioning surgical accessories like guide tubes in radiology and guiding catheter and wires in cardiology. With rising chronic disease prevalence associated with aging populations, the need for more surgical procedures is surging which requires precise action minimally invasive robotic systems can provide. The Global Medical Robots Market is estimated to be valued at US$ 11.47 Bn in 2024 and is expected to exhibit a CAGR of 16% over the forecast period 2023 to 2030. Key Takeaways: Key players operating in the Medical Robo...
Read more